402 related articles for article (PubMed ID: 22025246)
1. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking.
Nojiri H; Saita Y; Morikawa D; Kobayashi K; Tsuda C; Miyazaki T; Saito M; Marumo K; Yonezawa I; Kaneko K; Shirasawa T; Shimizu T
J Bone Miner Res; 2011 Nov; 26(11):2682-94. PubMed ID: 22025246
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic reactive oxygen species and SOD1 regulate bone mass during mechanical unloading.
Morikawa D; Nojiri H; Saita Y; Kobayashi K; Watanabe K; Ozawa Y; Koike M; Asou Y; Takaku T; Kaneko K; Shimizu T
J Bone Miner Res; 2013 Nov; 28(11):2368-80. PubMed ID: 23674366
[TBL] [Abstract][Full Text] [Related]
3. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
4. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis.
Huang Q; Gao B; Jie Q; Wei BY; Fan J; Zhang HY; Zhang JK; Li XJ; Shi J; Luo ZJ; Yang L; Liu J
Bone; 2014 Sep; 66():306-14. PubMed ID: 24933344
[TBL] [Abstract][Full Text] [Related]
7. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures.
Baek KH; Oh KW; Lee WY; Lee SS; Kim MK; Kwon HS; Rhee EJ; Han JH; Song KH; Cha BY; Lee KW; Kang MI
Calcif Tissue Int; 2010 Sep; 87(3):226-35. PubMed ID: 20614110
[TBL] [Abstract][Full Text] [Related]
8. Reduced proliferation and osteocalcin expression in osteoblasts of male idiopathic osteoporosis.
Ruiz-Gaspà S; Blanch-Rubió J; Ciria-Recasens M; Monfort J; Tío L; Garcia-Giralt N; Nogués X; Monllau JC; Carbonell-Abelló J; Pérez-Edo L
Calcif Tissue Int; 2010 Mar; 86(3):220-6. PubMed ID: 20101397
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
[TBL] [Abstract][Full Text] [Related]
10. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
[TBL] [Abstract][Full Text] [Related]
11. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
Fonseca TL; Jorgetti V; Costa CC; Capelo LP; Covarrubias AE; Moulatlet AC; Teixeira MB; Hesse E; Morethson P; Beber EH; Freitas FR; Wang CC; Nonaka KO; Oliveira R; Casarini DE; Zorn TM; Brum PC; Gouveia CH
J Bone Miner Res; 2011 Mar; 26(3):591-603. PubMed ID: 20814988
[TBL] [Abstract][Full Text] [Related]
12. Effects of cobalt and chromium ions at clinically equivalent concentrations after metal-on-metal hip replacement on human osteoblasts and osteoclasts: implications for skeletal health.
Andrews RE; Shah KM; Wilkinson JM; Gartland A
Bone; 2011 Oct; 49(4):717-23. PubMed ID: 21689801
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
14. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
[TBL] [Abstract][Full Text] [Related]
15. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I.
Cao JJ; Kurimoto P; Boudignon B; Rosen C; Lima F; Halloran BP
J Bone Miner Res; 2007 Aug; 22(8):1271-9. PubMed ID: 17488198
[TBL] [Abstract][Full Text] [Related]
16. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
17. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
[TBL] [Abstract][Full Text] [Related]
18. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis.
Xu ZS; Wang XY; Xiao DM; Hu LF; Lu M; Wu ZY; Bian JS
Free Radic Biol Med; 2011 May; 50(10):1314-23. PubMed ID: 21354302
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast dysfunction in male idiopathic osteoporosis.
Pernow Y; Granberg B; Sääf M; Weidenhielm L
Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
